Acasti Pharma reported CAD4.48M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acasti Pharma ACST:US C$ 4.48M 2.9M
Addus Homecare ADUS:US $ 112.53M 4.41M
Agile Therapeutics AGRX:US $ 9.57M 2.07M
Amarin AMRN:US $ 364.74M 5.69M
Bioscrip BIOS:US $ 485.66M 26.15M
Genetic Technologies GENE:US $ 1.41M 163.98K
Pain Therapeutics PTIE:US $ 6.33M 1.69M